| Q40643670 | Association of DDX58 177 C > T polymorphism with decreased risk of Epstein-Barr virus-related nodular sclerosis classical Hodgkin lymphoma. |
| Q36233047 | Comparative and temporal transcriptome analysis of peste des petits ruminants virus infected goat peripheral blood mononuclear cells |
| Q59351570 | Contribution of the KSHV and EBV lytic cycles to tumourigenesis |
| Q38838059 | Downregulation of Toll-Like Receptor 9 Expression by Beta Human Papillomavirus 38 and Implications for Cell Cycle Control. |
| Q38174306 | Dynamic Epstein-Barr virus gene expression on the path to B-cell transformation |
| Q40239476 | EBV MicroRNA BART16 Suppresses Type I IFN Signaling. |
| Q93018091 | Epstein-Barr Virus and Innate Immunity: Friends or Foes? |
| Q34874654 | Epstein-Barr virus encoded dUTPase containing exosomes modulate innate and adaptive immune responses in human dendritic cells and peripheral blood mononuclear cells |
| Q40046633 | Epstein-Barr virus infection and nasopharyngeal carcinoma |
| Q35105647 | Epstein-Barr virus large tegument protein BPLF1 contributes to innate immune evasion through interference with toll-like receptor signaling |
| Q39208715 | Evaluation of viral interference with MHC class I-restricted antigen processing and presentation using a flow cytometry-based approach |
| Q38111863 | Evasion of adaptive and innate immune response mechanisms by γ-herpesviruses |
| Q92314002 | Functional Polymorphisms and Gene Expression of TLR9 Gene as Protective Factors for Nasopharyngeal Carcinoma Severity and Progression |
| Q33979518 | Global mRNA degradation during lytic gammaherpesvirus infection contributes to establishment of viral latency. |
| Q38597254 | Immune Evasion by Epstein-Barr Virus |
| Q38597249 | Innate Immune Recognition of EBV. |
| Q37309928 | Innate immune responses against Epstein Barr virus infection |
| Q28080898 | Interference with the Autophagic Process as a Viral Strategy to Escape from the Immune Control: Lesson from Gamma Herpesviruses |
| Q92876934 | Investigating the TLR9 mRNA Expression Level in Different Histological Types of Colorectal Polyps |
| Q34277223 | Lactobacillus helveticus SBT2171 inhibits lymphocyte proliferation by regulation of the JNK signaling pathway |
| Q61448443 | MicroRNAs of Epstein-Barr Virus Attenuate T-Cell-Mediated Immune Control |
| Q35935783 | Murine gammaherpesvirus 68 infection protects lupus-prone mice from the development of autoimmunity |
| Q35531669 | Persistent infection drives the development of CD8+ T cells specific for late lytic infection antigens in lymphocryptovirus-infected macaques and Epstein-Barr virus-infected humans |
| Q35991530 | RNAs in Epstein-Barr virions control early steps of infection |
| Q26752361 | Shutoff of Host Gene Expression in Influenza A Virus and Herpesviruses: Similar Mechanisms and Common Themes |
| Q90369286 | TLR9 Polymorphisms Might Contribute to the Ethnicity Bias for EBV-Infected Nasopharyngeal Carcinoma |
| Q37150541 | TLR9 re-expression in cancer cells extends the S-phase and stabilizes p16(INK4a) protein expression |
| Q36154936 | The "Bridge" in the Epstein-Barr virus alkaline exonuclease protein BGLF5 contributes to shutoff activity during productive infection |
| Q34277034 | The EBV immunoevasins vIL-10 and BNLF2a protect newly infected B cells from immune recognition and elimination |
| Q39219487 | The Immune Response to Epstein Barr Virus and Implications for Posttransplant Lymphoproliferative Disorder |
| Q54245037 | The Immunomodulatory Capacity of an Epstein-Barr Virus Abortive Lytic Cycle: Potential Contribution to Viral Tumorigenesis. |
| Q42266941 | The T antigen locus of Merkel cell polyomavirus downregulates human Toll-like receptor 9 expression. |
| Q36283649 | The emerging role of nuclear viral DNA sensors |
| Q36973683 | The human papillomavirus type 16 E7 oncoprotein induces a transcriptional repressor complex on the Toll-like receptor 9 promoter |
| Q40063898 | Toll-like receptor 5 and 7 expression may impact prognosis of HPV-positive oropharyngeal squamous cell carcinoma patients |
| Q33928402 | Toll-like receptor 9 in breast cancer |
| Q38051643 | Toll-like receptor sensing of human herpesvirus infection |
| Q40046657 | Tumour viruses and innate immunity |